Document Detail


Neonatal Drug Withdrawal.
MedLine Citation:
PMID:  22291123     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Maternal use of certain drugs during pregnancy can result in transient neonatal signs consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting drug effect. In addition, hospitalized infants who are treated with opioids or benzodiazepines to provide analgesia or sedation may be at risk for manifesting signs of withdrawal. This statement updates information about the clinical presentation of infants exposed to intrauterine drugs and the therapeutic options for treatment of withdrawal and is expanded to include evidence-based approaches to the management of the hospitalized infant who requires weaning from analgesics or sedatives.
Authors:
Mark L Hudak; Rosemarie C Tan; ;
Related Documents :
16959433 - Prenatal influences on brain dopamine and their relevance to the rising incidence of au...
15253483 - Elements in placenta and pregnancy outcome in arctic and subarctic areas.
3565813 - Postoperative apnea in preterm infants.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-30
Journal Detail:
Title:  Pediatrics     Volume:  -     ISSN:  1098-4275     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dispensing Medications at the Hospital Upon Discharge From an Emergency Department.
Next Document:  Fetal and Maternal Candidate Single Nucleotide Polymorphism Associations With Cerebral Palsy: A Case...